4/11
08:06 am
fate
Fate Therapeutics, Inc. (NASDAQ: FATE) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Medium
Report
Fate Therapeutics, Inc. (NASDAQ: FATE) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
4/6
04:00 am
fate
Fate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress [Yahoo! Finance]
Medium
Report
Fate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress [Yahoo! Finance]
4/3
08:24 am
fate
Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
Low
Report
Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
4/3
08:00 am
fate
Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference
Low
Report
Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference
4/2
04:01 pm
fate
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
3/27
01:29 pm
fate
Fate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Low
Report
Fate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
3/19
08:56 am
fate
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement [Yahoo! Finance]
Low
Report
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement [Yahoo! Finance]
3/19
08:44 am
fate
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
Low
Report
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
2/26/2024
04:01 pm
FATE
fate therapeutics, inc.
BEAT
Report
7.3%
fate therapeutics, inc.
11/8/2023
04:01 pm
FATE
fate therapeutics, inc.
BEAT
Report
-8.6%
fate therapeutics, inc.
8/8/2023
04:01 pm
FATE
fate therapeutics, inc.
BEAT
Report
-3.7%
fate therapeutics, inc.
5/3/2023
04:01 pm
FATE
fate therapeutics, inc.
BEAT
Report
-2.4%
fate therapeutics, inc.
4/16
04:06 pm
fate
Form PRE 14A FATE THERAPEUTICS INC For: Jun 07
Low
Report
Form PRE 14A FATE THERAPEUTICS INC For: Jun 07
3/25
09:31 pm
fate
Form 4 FATE THERAPEUTICS INC For: Mar 21 Filed by: Redmile Group, LLC
Low
Report
Form 4 FATE THERAPEUTICS INC For: Mar 21 Filed by: Redmile Group, LLC
3/25
05:15 pm
fate
Form SC 13D/A FATE THERAPEUTICS INC Filed by: Redmile Group, LLC
Medium
Report
Form SC 13D/A FATE THERAPEUTICS INC Filed by: Redmile Group, LLC
3/21
06:01 am
fate
Form 8-K FATE THERAPEUTICS INC For: Mar 19
Medium
Report
Form 8-K FATE THERAPEUTICS INC For: Mar 19
3/20
05:31 pm
fate
Form 424B5 FATE THERAPEUTICS INC
Low
Report
Form 424B5 FATE THERAPEUTICS INC
3/5
04:24 pm
fate
Form 4 FATE THERAPEUTICS INC For: Mar 04 Filed by: Dulac Edward J III
High
Report
Form 4 FATE THERAPEUTICS INC For: Mar 04 Filed by: Dulac Edward J III
3/4
01:29 pm
fate
Form 144 FATE THERAPEUTICS INC Filed by: Dulac Edward J III
Low
Report
Form 144 FATE THERAPEUTICS INC Filed by: Dulac Edward J III
2/26
04:13 pm
fate
Form 10-K FATE THERAPEUTICS INC For: Dec 31
Medium
Report
Form 10-K FATE THERAPEUTICS INC For: Dec 31
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register